Advances in Lung Cancer Treatment
Keith D. Eaton, MD, PhD reflects on the past 15 years of his career and discusses advancements in lung cancer treatment. He focuses on metastatic Non-Small Cell Lung Cancer (NSCLC) and the outcomes of targeted therapies.
Related Presenters
UW Medicine Clinical Director of THN Oncology, UW Professor of Oncology, Associate Professor of Medicine
Keith Eaton, M.D., is a board certified oncologist at SCCA and a UW professor of Oncology and associate professor of Medicine.